¿¬¼ö°­ÁÂ
´ëÇѳúÇ÷°ü³»¼ö¼úÇÐȸ ENSURE 2019 (³úµ¿¸Æ·ù Ç÷·ùÀüȯÀ¯µµ ½ºÅÙÆ® ½ÉÆ÷Áö¾ö(ENSURE) ¹× ´ëÇѳúÇ÷°ü³»¼ö¼úÇÐȸ 2019 Ã߰躸¼ö±³À°) : 2019-09-28
´ëÇѳúÇ÷°ü³»¼ö¼úÇÐȸ ENSURE 2019 (³úµ¿¸Æ·ù Ç÷·ùÀüȯÀ¯µµ ½ºÅÙÆ® ½ÉÆ÷Áö¾ö(ENSURE) ¹× ´ëÇѳúÇ÷°ü³»¼ö¼úÇÐȸ 2019 Ã߰躸¼ö±³À°) : 2019-09-28
±³À°ÀÏÀÚ : 2019-09-28
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : ENSURE 2019 (³úµ¿¸Æ·ù Ç÷·ùÀüȯÀ¯µµ ½ºÅÙÆ® ½ÉÆ÷Áö¾ö(ENSURE) ¹× ´ëÇѳúÇ÷°ü³»¼ö¼úÇÐȸ 2019 Ã߰躸¼ö±³À°)
ÁÖÃÖ±â°ü : ´ëÇѽŰæ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѳúÇ÷°ü³»¼ö¼úÇÐȸ  
´ã´çÀÚ : Á¤È¿°æ
¿¬¶ôó : 02-2279-9560  
À̸ÞÀÏ : sken@sken.kr      
±³À°Á¾·ù : ½Å°æ¿Ü°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 110,000¿ø      
ºñ°í »çÀüµî·Ï ⸳ȸ¿ø: ¹«·á/ ÀüÀÓȸÀå´Ü: ¹«·á/ Á¤È¸¿ø(¿¬È¸ºñ³³ºÎ): 30,000¿ø/ Á¤È¸¿ø(¿¬È¸ºñ ¹Ì³³ºÎ): 50,000¿ø/ °øº¸ÀÇ,±ºÀÇ°ü: 20,000¿ø/ °£È£»ç,¹æ»ç¼±»ç,Àü°øÀÇ: 20,000¿ø/ ºñȸ¿ø: 100,000¿ø  ÇöÀåµî·Ï ⸳ȸ¿ø: 10,000¿ø/ ÀüÀÓȸÀå´Ü: 10,000¿ø/ Á¤È¸¿ø(¿¬È¸ºñ³³ºÎ): 40,000¿ø/ Á¤È¸¿ø(¿¬È¸ºñ ¹Ì³³ºÎ): 60,000¿ø/ °øº¸ÀÇ,±ºÀÇ°ü: 30,000¿ø/ °£È£»ç,¹æ»ç¼±»ç,Àü°øÀÇ: 30,000¿ø/ ºñȸ¿ø: 110,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:30~09:50 Pathogenesis and natural history of unusual aneurysm - A. Dissecting aneurysm.  ±Ç¿À±â(ºÐ´ç¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:50~10:10 Pathogenesis and natural history of unusual aneurysm - B. Giant thrombosed aneurysm.  °íÁØ°æ(ºÎ»ê´ëº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:10~10:30 Dynamic blood flow analysis with aneurysmal CFD study  ±è¿ë¹è(¿¬¼¼´ë °­³²¼¼ºê¶õ½ºº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:30~10:50 Endovascular role of flow-diverter & its world-wide indication  ±Ç¼øÂù(¿ï»ê´ëº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:10~11:30 Review of recent trial for flow diversion - A. Pros.  ±ÇÇöÁ¶(Ãæ³²´ëº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:30~11:50 Review of recent trial for flow diversion - B. Cons.  ±èÅñÕ(ºÐ´ç¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:50~12:05 Flow diversion beyond the circle of Willis  ¹Ú¼®±Ô(¼øõÇâ´ë ¼­¿ïº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 12:05~12:20 Evolving flow-diverters and its supporting devices  ±è´ë¿ø(¿ø±¤´ëº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 12:20~13:30 Parallel hands on training with vessel model  ½Å½ÂÈÆ(´ëÇѳúÇ÷°ü³»¼ö¼úÇÐȸ Ãѹ«ÀÌ»ç) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 13:30~13:50 Flow-diverter for anterior circulation aneurysm.  ½Å¿ë»ï(°¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 13:50~14:10 Flow-diverter for posterior circulation aneurysm.  °­Çö½Â(¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:10~14:25 How to prevent and get out of complications due to FD  ±è¼º¸²(°¡Å縯´ë ºÎõ¼º¸ðº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:25~14:40 How to do? medication & imaging follow-up for FD  ±èÅ°ï(Â÷ÀÇ°úÇÐ´ë ºÐ´çÂ÷º´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:00~15:15 Unruptured basilar fusiform aneurysm, How I do it?  ÀÓÁ¾±¹(Á¦Áִ뺴¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:15~15:30 A giant aneurysm on vertebrobasilar junction: How I do it?  ½ÅÈñ¼·(°­µ¿°æÈñ´ëº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:30~15:45 Endovascular treatment using coil versus flow diverter stent for vertebrobasilar aneurysm  ÀÌÁ¾¿µ(ÇѸ²´ë °­µ¿¼º½Éº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:45~16:00 Parent artery occlusion for giant intracranial aneurysm in a 11-year-old girl  ±è¿µ¿ì(°¡Å縯´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:00~16:15 Endovascular treatment of ruptured fusiform aneurysm of the basilar artery  ±è´ë¿ø(¿ø±¤´ëº´¿ø ½Å°æ¿Ü°ú) 
±³À°½Ã°£ 09-28 °¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:15~16:30 Multi-sesseion endovascular treatment of ruptured recurrent M1 dissecting aneurysm  ÀÌÀçÀÏ(ºÎ»ê´ëº´¿ø ½Å°æ¿Ü°ú) 
  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,657 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,712 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-16

±³À°ÀÏÀÚ : 2024-03-16 ±³À°Àå¼Ò : ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÄ¡¸ÅÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,708 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼¼ºê¶õ½ºº´¿ø 2018 ¼¼¸ñȸ Çмú´ëȸ : 2018-11-10

±³À°ÀÏÀÚ : 2018-11-10 ±³À°Àå¼Ò : °­³² ¼¼ºê¶õ½ºº´¿ø ´ë°­´ç ±³À°ÁÖÁ¦ : 2018 ¼¼¸ñȸ Çмú´ëȸ ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø ½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú ´ã´çÀÚ : ¹Ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,392 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,398 , ´ñ±Û¼ö : 0